FTO缺陷通过破坏CerS6介导的鞘脂代谢加重溃疡性结肠炎
研究探讨FTO(一种m6A去甲基化酶)在溃疡性结肠炎(UC)中的作用。在Ftoflox/flox;Villin-cre小鼠DSS模型中,FTO缺陷导致CerS6 mRNA稳定性下降、S1P在肠上皮细胞中蓄积,经巨噬细胞分泌血清淀粉样蛋白A1/3诱导Th17细胞分化而加重结肠炎;UC患者FTO低表达者可能对维得利珠单抗应答更好。
要点
- UC患者结肠组织FTO表达下调,见于本中心队列和外部队列。
- FTO缺陷使CerS6 m6A修饰增加、mRNA稳定性下降,S1P在肠上皮细胞蓄积。
- 肠上皮细胞分泌S1P触发促炎巨噬细胞分泌血清淀粉样蛋白A1/3,诱导Th17细胞分化。
核心结论
- FTO下调通过降低CerS6表达、增加肠上皮细胞S1P蓄积,经m6A依赖机制加重溃疡性结肠炎。
- UC患者FTO低表达可能增强其对维得利珠单抗治疗的应答。
研究设计与样本
- 研究分析Ftoflox/flox;Villin-cre小鼠及其Ftoflox/flox同窝对照在葡聚糖硫酸钠(DSS)处理下的结肠组织,采用实时PCR和16s rRNA测序。
- 采用RNA免疫沉淀测序和甲基化RNA免疫沉淀测序分析免疫细胞和肠上皮细胞。
- 用FTO敲低MODE-K细胞的条件培养基或鞘氨醇-1-磷酸(S1P)处理巨噬细胞并分析基因表达。
- 采用液相色谱-质谱法鉴定C16-神经酰胺。
- 分析本中心队列和外部UC患者队列的结肠组织。
主要发现
- 在本中心队列和外部UC患者队列中均发现FTO下调。
- DSS处理的Ftoflox/flox;Villin-cre小鼠出现肠道菌群失调、促炎巨噬细胞浸润增加和Th17细胞分化增强。
- FTO缺陷导致CerS6的m6A修饰增加、mRNA稳定性下降,CerS6表达下调,肠上皮细胞中S1P蓄积。
- 肠上皮细胞分泌的S1P触发促炎巨噬细胞分泌血清淀粉样蛋白A1/3,最终诱导Th17细胞分化。
- 通过生物信息学分析和实验验证,发现FTO表达较低的UC患者可能对维得利珠单抗治疗应答更好。
临床怎么用
- 作者认为,UC患者FTO低表达可能增强其对维得利珠单抗治疗的应答。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Deregulation of RNA N6-methyladenosine (m6A) modification in intestinal epithelial cells (IECs) influences intestinal immune cells and leads to intestinal inflammation. We studied the function of fat mass-and obesity-associated protein (FTO), one of the m6A demethylases, in patients with ulcerative colitis (UC). METHODS: We analysed colon tissues of Ftoflox/flox; Villin-cre mice and their Ftoflox/flox littermates with dextran sulfate sodium (DSS) using real-time PCR and 16s rRNA sequencing. RNA and methylated RNA immunoprecipitation sequencing were used to analyse immunocytes and IECs. Macrophages were treated with conditioned medium of FTO-knockdown MODE-K cells or sphingosine-1-phosphate (S1P) and analysed for gene expression. Liquid chromatograph mass spectrometry identified C16-ceramide. RESULTS: FTO downregulation was identified in our in-house cohort and external cohorts of UC patients. Dysbiosis of gut microbiota, increased infiltration of proinflammatory macrophages, and enhanced differentiation of Th17 cells were observed in Ftoflox/flox;Villin-cre mice under DSS treatment. FTO deficiency resulted in an increase in m6A modification and a decrease in mRNA stability of CerS6, the gene encoding ceramide synthetase, leading to the downregulation of CerS6 and the accumulation of S1P in IECs. Subsequentially, the secretion of S1P by IECs triggered proinflammatory macrophages to secrete serum amyloid A protein 1/3, ultimately inducing Th17 cell differentiation. In addition, through bioinformatic analysis and experimental validation, we identified UC patients with lower FTO expression might respond better to vedolizumab treatment. CONCLUSIONS: FTO downregulation promoted UC by decreasing CerS6 expression, leading to increased S1P accumulation in IECs and aggravating colitis via m6A-dependent mechanisms. Lower FTO expression in UC patients may enhance their response to vedolizumab treatment.
引用
- Ma Y, Zhang X, Xuan B, et al. Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis. Gut. 2024. PMID: 37734910. doi:10.1136/gutjnl-2023-330009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。